Board committees

Board of Directors:

Anders Ekblom

Chairman of the Board

Chairman of the Board since 2021
Chairman of the Remuneration Committee
Born 1954

Education: M.D., Board certified in Anesthesiology and Intensive Care, D.D.S., Associate Professor in Physiology, Karolinska Institutet

Other current activities: Chairman of the Board of Alligator Bioscience AB, and Atrogi AB, Member of the Board of Synkerkine Pharma B.V., Flerie AB, Mereo BioPharma Group plc, and NxtScience AB, and Deputy director of Xspray Pharma Futurum AB

Holdings: 5,500 shares, 13 214 warrants (LTIP 2021/2026)

Independent in relation to the Company and its management, but not in relation to major shareholders

Anders Bladh

Board member since 2021

Member of the Remuneration Committee
Born 1958

Education: Bachelor of Science in Business Administration and Economics, University of Uppsala

Other current activities: Owner and Chairman of the Board of Intervalor AB, Chairman of the Board of DistIT AB, Member of the Board of Ribbskottet AB, Rimturs AB, and Umecrine Cognition AB

Holdings: 274,670 shares, and 4,300,000 shares via company Ribbskottet AB

Independent in relation to the Company and its management, but not in relation to major shareholders.

Markus Haeberlein

Board member

Board member since 2025
Resides in the USA
Born 1969

Education: M.Sc. and Ph.D. in Physical Chemistry/Computational Chemistry from Royal Institute of Technology, KTH, Stockholm

Other current activities: Executive Vice President , Discovery Science at Parabilis Medicines, Cambridge, Massachusetts, USA

Holdings in Xspray Pharma: 0

Independent in relation to the Company and its management and in relation to major shareholders

Christine Lind

Board member

Board member since 2019
Chairman of the Audit Committee
Born 1974

Education: Bachelors in Science in Finance and information Systems, New York University, Masters in Business Administration in Finance and Management, Columbia Business School

Other current activities: Other current activities: CEO of Bactiguard AB, and Bactiguard Holding AB, Chairman and CEO of Lind Growth Strategy AB, Member of the Board of Shinka Life Sciences AB

Holdings: 7,368 shares

Independent in relation to the Company and its management and in relation to major shareholders

Robert Molander

Board member

Board member since 2022
Resides in the USA
Born 1965

Education: MBA from Washington University and two bachelor’s degrees from Miami University in Economics and International Studies

Other current activities: Owner and CEO of Stratfox Healthcare Group LLC, partner of IRL MD Food Solutions, and Member of the Board of SciBase Intressenter AB, SciBase Holding AB (publ), SciBase AB, and Biosergen AB

Holdings: 10,000 shares

Independent in relation to the Company and its management and in relation to major shareholders

Anne Prener

Board member

Board member since 2025
Resides in Denmark
Born 1957

Education: M.D., PhD. from Copenhagen University

Other current activities: Senior Innovation Advisor at University of Copenhagen, non-executive Board member of Galecto Inc.

Holdings: 0

Independent in relation to the Company and its management and in relation to major shareholders

Carl-Johan Spak

Board member

Board member since 2015
Member of the Audit Committee
Born 1956

Education: Dr. of Odontology, Degree in Dentistry, Karolinska Institutet

Other current activities: Member of the Board of Atrogi AB, EpiEndo ehf, Lipum AB, Symcel AB, and Buzzard Pharmaceuticals AB

Holdings: 0

Independent in relation to the Company and its management and in relation to major shareholders

Committees:

Audit Committee

  • Christine Lind, Chairman
  • Anne Prener
  • Carl-Johan Spak

Remuneration Committee

  • Anders Ekblom, Chairman
  • Anders Bladh
  • Robert Molander